Autopsy report · NCT01800500

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

“Difficulty accruing”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 5 months after it had already started.
• 72 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Roswell Park Cancer Institute

Sponsor type

University, hospital or other

Conditions

Tobacco Use Disorder

Interventions

smoking cessation intervention; smoking cessation intervention; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis; ecigarettes

Participants

72

Sites

1

Countries

United States

Trials that died the same way

• Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
  “Accrual difficulties” (79% match in meaning)
• Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer
  “failure to accrue” (70% match in meaning)
• A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms
  “unable to accrue” (68% match in meaning)
• Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer
  “Insufficient accrual” (68% match in meaning)
• The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
  “Slow/insufficient accrual” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.